Shares in Salesforce (NYSE: CRM) surged more than 10% in after-hours trading following the release of the company's fiscal Q3 2025 earnings report. The company exceeded revenue expectations, raised ...
EBR Systems (ASX:EBR) has announced that the US Food and Drug Administration (FDA) will conduct a Pre-Approval Inspection of its manufacturing facility during the week commencing 6 January 2025. The ...